blog address: https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html
keywords: roots analysis, market, research, biotech, pharma
member since: Nov 15, 2021 | Viewed: 415
Category: Health
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors London Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings. Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players. To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html Contact Details Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com
Health
Health
Health
Health
Health
Health